177lu-psma-617
novartis
['prostate', 'psmaddition', 'novartis']
want to learn about trials in progress at #asco23? check out abstract no. tps5116 on sat, june 3 from 8 to 11 am cdt for the latest novartis presentation from the #psmaddition phase 3 study on rlt plus soc vs soc alone in patients with metastatic hormone-sensitive prostate cancer
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu